Preferred Label : Lapatinib/Letrozole/Trastuzumab Regimen;
NCIt synonyms : Lapatinib/Letrozole/Herceptin; Letrozole/Lapatinib/Trastuzumab; Lapatinib/Letrozole/Trastuzumab; Letrozole/Lapatinib/Trastuzumab Regimen; Lapatinib-Letrozole-Trastuzumab; Lapatinib-Letrozole-Trastuzumab Regimen;
NCIt related terms : Lapatinib, Letrozole, Trastuzumab; Lapatinib, Letrozole, Trastuzumab-dttb; Lapatinib, Letrozole, Trastuzumab-herw; Lapatinib, Letrozole, Trastuzumab-qyyp; Lapatinib, Letrozole, Trastuzumab-zerc; Lapatinib, Letrozole, Trastuzumab-dkst; Lapatinib, Letrozole, Trastuzumab-anns; Lapatinib, Letrozole, Trastuzumab-pkrb;
NCIt definition : A regimen consisting of lapatinib, letrozole, and trastuzumab that can be used in
the treatment of breast cancer.;
NCI Metathesaurus CUI : CL563137;
Codes from synonyms : 9205; 128816; 129204; 129107; 128913; 129301; 129010; 129398;
Origin ID : C156307;
UMLS CUI : C4744731;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
